PharmaCielo Overview
- Year Founded
-
2014

- Status
-
Public
- Employees
-
268

- Stock Symbol
-
PCLO

- Investments
-
4
- Share Price
-
$0.15
- (As of Monday Closing)
PharmaCielo General Information
Description
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.
Contact Information
- 82 Richmond Street East
- Toronto, Ontario M5C 1P1
- Canada
PharmaCielo Timeline
PharmaCielo Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.15 | $0.15 | $0.08 - $0.34 | $23.6M | 159M | 151K | -$0.07 |
PharmaCielo Financials Summary
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 33,773 | 27,654 | 112,472 | 224,099 |
Revenue | 2,189 | 4,074 | 1,551 | 1,978 |
EBITDA | (8,751) | (9,616) | (19,806) | (31,351) |
Net Income | (11,362) | (11,141) | (21,231) | (32,608) |
Total Assets | 19,492 | 18,506 | 28,201 | 34,525 |
Total Debt | 11,600 | 9,274 | 6,612 | 3,508 |
PharmaCielo Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
PharmaCielo Comparisons
Industry
Financing
Details
PharmaCielo Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000000 0000 000000 | Corporation | Toronto, Canada | 000 | 000.00 | 00000000 | 000.00 |
PharmaCielo Executive Team (17)
PharmaCielo Board Members (14)
Name | Representing | Role | Since |
---|---|---|---|
Douglas Bache | PharmaCielo | Board Member | 000 0000 |
Ian Atacan | PharmaCielo | Chief Financial Officer, Finance & Board Member | 000 0000 |
Marc Lustig | Self | Board Member | 000 0000 |
William Petron | PharmaCielo | Chief Executive Officer & Board Member | 000 0000 |
PharmaCielo Signals
PharmaCielo Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
PharmaCielo Investments & Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 000000 | 26-Jul-2019 | 0000000000 | 00.000 | Other Healthcare Technology Systems | 0000000 0 |
00000000000 0 | 25-Jan-2019 | 00000 0000 | Pharmaceuticals | 00000 000 | |
000 0000000 0 | 15-Jan-2019 | 0000000000 | Special Purpose Acquisition Company (SPAC) | ||
3.37 hectares land (Bogota) | 17-May-2017 | Corporate Asset Purchase | Buildings and Property | 00000000 |
PharmaCielo ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Pharmaceuticals
Subindustry
Rank
Percentile
